NO20053890L - Synthesis of 4-amino-2-butenol chlorides and their use in the preparation of 3-cyanoquinolines - Google Patents

Synthesis of 4-amino-2-butenol chlorides and their use in the preparation of 3-cyanoquinolines

Info

Publication number
NO20053890L
NO20053890L NO20053890A NO20053890A NO20053890L NO 20053890 L NO20053890 L NO 20053890L NO 20053890 A NO20053890 A NO 20053890A NO 20053890 A NO20053890 A NO 20053890A NO 20053890 L NO20053890 L NO 20053890L
Authority
NO
Norway
Prior art keywords
preparation
cyanoquinolines
butenol
chlorides
synthesis
Prior art date
Application number
NO20053890A
Other languages
Norwegian (no)
Other versions
NO20053890D0 (en
Inventor
Jr John Leo Considine
Sylvain Daigneault
Warren Chew
Silvio Iera
Scott Mason Duncan
Jianxin Ren
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32825162&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20053890(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20053890D0 publication Critical patent/NO20053890D0/en
Publication of NO20053890L publication Critical patent/NO20053890L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/30—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Det beskrives en forbindelse med formel (I): hvor S1 og S2 hver uavhengig er hydrogen, alkyl, alkenyl, alkynyl, aralkyl, substituert eller usubstituert aryl, og hvor S1 og S2 sammen med det nitrogen som de er tilknyttet, danner en nitrogenholdig heteroaryl, og et farmasøytisk akseptabelt salt derav; en fremgangsmåte for fremstilling av forbindelsen med formel (I) og anvendelse av forbindelsen med formel (I) ved fremstillingen av 3-cyanokinoliner.A compound of formula (I) is disclosed: wherein S1 and S2 are each independently hydrogen, alkyl, alkenyl, alkynyl, aralkyl, substituted or unsubstituted aryl, and wherein S1 and S2 together with the nitrogen to which they are attached form a nitrogen-containing heteroaryl and a pharmaceutically acceptable salt thereof; a process for the preparation of the compound of formula (I) and use of the compound of formula (I) in the preparation of 3-cyanoquinolines.

NO20053890A 2003-01-21 2005-08-19 Synthesis of 4-amino-2-butenol chlorides and their use in the preparation of 3-cyanoquinolines NO20053890L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44147003P 2003-01-21 2003-01-21
PCT/US2004/001133 WO2004066919A2 (en) 2003-01-21 2004-01-16 Synthesis of 4amino-2-butenoyl chlorides and their use in the preparation of 3-cyano quinolines

Publications (2)

Publication Number Publication Date
NO20053890D0 NO20053890D0 (en) 2005-08-19
NO20053890L true NO20053890L (en) 2005-10-20

Family

ID=32825162

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053890A NO20053890L (en) 2003-01-21 2005-08-19 Synthesis of 4-amino-2-butenol chlorides and their use in the preparation of 3-cyanoquinolines

Country Status (15)

Country Link
US (1) US7126025B2 (en)
EP (1) EP1585479A2 (en)
CN (1) CN100537518C (en)
AR (1) AR042877A1 (en)
AU (1) AU2004207475A1 (en)
CA (1) CA2514550A1 (en)
CL (2) CL2004000016A1 (en)
CR (1) CR7950A (en)
EC (1) ECSP055974A (en)
MX (1) MXPA05008876A (en)
NO (1) NO20053890L (en)
RU (1) RU2345984C2 (en)
SG (1) SG166678A1 (en)
TW (1) TW200418763A (en)
WO (1) WO2004066919A2 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA77200C2 (en) 2001-08-07 2006-11-15 Wyeth Corp Antineoplastic combination of cci-779 and bkb-569
CL2004000016A1 (en) 2003-01-21 2005-04-15 Wyeth Corp 4-AMINO-2-BUTENOYL CHLORIDE COMPOUND OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME; PROCEDURE TO PREPARE SUCH COMPOUND, USEFUL AS INTERMEDIARY IN THE SYNTHESIS OF INHIBITING COMPOUNDS OF PROTEIN QUINASA TIROSINA.
WO2005061519A1 (en) 2003-12-19 2005-07-07 Takeda San Diego, Inc. Kinase inhibitors
CA2553729A1 (en) * 2004-01-16 2005-08-04 Wyeth Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof
US7550598B2 (en) 2004-08-18 2009-06-23 Takeda Pharmaceutical Company Limited Kinase inhibitors
DE602005023333D1 (en) 2004-10-15 2010-10-14 Takeda Pharmaceutical KINASE INHIBITORS
CN108421044A (en) 2005-02-03 2018-08-21 综合医院公司 The method for treating gefitinib resistant cancer
RU2007140957A (en) * 2005-05-25 2009-06-27 Вайет (Us) METHODS FOR SYNTHESIS OF 6-ALKYLAMINOCHINOLINE DERIVATIVES
BRPI0610147A2 (en) * 2005-05-25 2010-06-01 Wyeth Corp method for preparing and synthesizing substituted 3-cyanoquinolines and 4-amino-3-cyanoquinolines
CN101180269A (en) * 2005-05-25 2008-05-14 惠氏公司 Process for the preparation of 3-cyano-quinolines and intermediates made therefrom
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
BRPI0618042A2 (en) 2005-11-04 2011-08-16 Wyeth Corp uses of a rapamycin and herceptin, product, pharmaceutical package, and, pharmaceutical composition
EP1948179A1 (en) 2005-11-11 2008-07-30 Boehringer Ingelheim International GmbH Quinazoline derivatives for the treatment of cancer diseases
SG158147A1 (en) 2006-10-09 2010-01-29 Takeda Pharmaceutical Kinase inhibitors
US8022216B2 (en) 2007-10-17 2011-09-20 Wyeth Llc Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
CN102641270A (en) 2008-06-17 2012-08-22 惠氏有限责任公司 Antineoplastic combinations containing HKI-272 and vinorelbine
US8669273B2 (en) 2008-08-04 2014-03-11 Wyeth Llc Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine
WO2010048477A2 (en) * 2008-10-24 2010-04-29 Wyeth Llc Improved process for preparation of coupled products from 4-amino-3-cyanoquinolines using stabilized intermediates
CN102216256A (en) * 2008-11-17 2011-10-12 诺瓦提斯公司 Enantioselective synthesis of gamma-amino-alpha,beta-unsaturated carboxylic acid derivative
IL264349B2 (en) 2009-04-06 2024-01-01 Wyeth Llc Regimens containing neratinib for the treatment of cancer
WO2010131921A2 (en) * 2009-05-14 2010-11-18 코오롱생명과학 주식회사 Method for producing an alkyl amine derivative
PL2451445T3 (en) 2009-07-06 2019-09-30 Boehringer Ingelheim International Gmbh Process for drying of bibw2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient
NZ599762A (en) 2009-11-09 2014-07-25 Wyeth Llc Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea
CN102731395B (en) * 2011-04-15 2015-02-04 中国科学院上海药物研究所 Intermediate compound of antitumor drug neratinib and its preparation method and use
US9242965B2 (en) 2013-12-31 2016-01-26 Boehringer Ingelheim International Gmbh Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors
CN104926669A (en) * 2014-03-18 2015-09-23 江苏豪森医药集团连云港宏创医药有限公司 Preparation method of trans-4-dimethylaminocrotonic acid hydrochloride
WO2015186065A1 (en) 2014-06-02 2015-12-10 Sun Pharmaceutical Industries Limited Process for the preparation of 4-dimethylaminocrotonic acid
CN105439879B (en) * 2014-08-07 2018-08-10 天津法莫西医药科技有限公司 A kind of preparation method of trans- -4- dimethylamino cronate hydrochlorate
CN105669479B (en) * 2015-12-31 2018-04-13 重庆威鹏药业有限公司 The method that one kettle way prepares the trans 4 dimethyl amido cronate hydrochlorate of high-purity
BR112018071617A2 (en) * 2016-04-28 2019-02-19 Jiangsu Hengrui Medicine Co., Ltd. method for preparing tyrosine kinase inhibitor and derivative thereof
US11407734B2 (en) 2017-10-18 2022-08-09 Jiangsu Hengrui Medicine Co., Ltd. Preparation method for tyrosine kinase inhibitor and intermediate thereof
CN111217850B (en) * 2019-01-31 2023-05-26 微宏先进材料公司 Preparation method of silicon-based ester compound, electrolyte containing silicon-based ester compound and secondary battery
CN112679473B (en) * 2019-10-18 2024-03-05 四川科伦药物研究院有限公司 Lenatinib intermediate crystal, preparation method and application thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194050A (en) 1976-04-30 1980-03-18 Sumitomo Chemical Company, Limited Process for producing an enamide
US4195021A (en) 1977-10-26 1980-03-25 Eli Lilly And Company 1,3-Disubstituted 2-azetidinone antibitotics
US4193983A (en) 1978-05-16 1980-03-18 Syva Company Labeled liposome particle compositions and immunoassays therewith
BE897134A (en) 1983-06-24 1983-12-27 Solvay POLYSUBSTITUED DIENES
US4478959A (en) 1983-09-29 1984-10-23 Air Products And Chemicals, Inc. Amino and amido divalent metal carboxylates useful as catalysts for polyurethane formulations
DE3347659A1 (en) 1983-12-31 1985-07-11 Bayer Ag, 5090 Leverkusen NEW PAINT SOLUTIONS BASED ON HYDANTOING GROUPS OF POLYMERS
US4664825A (en) 1984-10-25 1987-05-12 The Lubrizol Corporation Sulfurized compositions and lubricants containing them
AU634871B2 (en) 1990-03-20 1993-03-04 Banyu Pharmaceutical Co., Ltd. Substituted amine derivatives having anti-hyperlipemia activity
US6002008A (en) 1997-04-03 1999-12-14 American Cyanamid Company Substituted 3-cyano quinolines
UA73073C2 (en) 1997-04-03 2005-06-15 Уайт Холдінгз Корпорейшн Substituted 3-cyan chinolines
UA77200C2 (en) 2001-08-07 2006-11-15 Wyeth Corp Antineoplastic combination of cci-779 and bkb-569
CL2004000016A1 (en) 2003-01-21 2005-04-15 Wyeth Corp 4-AMINO-2-BUTENOYL CHLORIDE COMPOUND OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME; PROCEDURE TO PREPARE SUCH COMPOUND, USEFUL AS INTERMEDIARY IN THE SYNTHESIS OF INHIBITING COMPOUNDS OF PROTEIN QUINASA TIROSINA.

Also Published As

Publication number Publication date
RU2005126418A (en) 2006-01-27
CL2007001286A1 (en) 2008-01-25
AR042877A1 (en) 2005-07-06
US7126025B2 (en) 2006-10-24
CN1761644A (en) 2006-04-19
WO2004066919A2 (en) 2004-08-12
SG166678A1 (en) 2010-12-29
NO20053890D0 (en) 2005-08-19
ECSP055974A (en) 2006-01-16
RU2345984C2 (en) 2009-02-10
CR7950A (en) 2006-05-30
US20040162442A1 (en) 2004-08-19
CL2004000016A1 (en) 2005-04-15
MXPA05008876A (en) 2005-10-05
CA2514550A1 (en) 2004-08-12
WO2004066919A3 (en) 2005-01-27
EP1585479A2 (en) 2005-10-19
TW200418763A (en) 2004-10-01
AU2004207475A1 (en) 2004-08-12
CN100537518C (en) 2009-09-09

Similar Documents

Publication Publication Date Title
SG166678A1 (en) Synthesis of 4amino-2-butenoyl cholrides and their use in the preparation of 3-cyano quinolines
NO20054538L (en) Process for the preparation of topiramate anticonvulsant derivatives
NO20064077L (en) Kemokinreseptorantagonister
NO20075169L (en) New imidazo (1,5-A) ornamental derivatives, process for preparation and pharmaceutical compositions containing the same.
MY140528A (en) Spiroketal derivatives and their use as therapeutic agents for diabetes
EA200970171A1 (en) DERIVATIVES N- (AMINOHETEROARIL) -1H-INDOL-2-CARBOXAMIDES, THEIR RECEIVING AND THEIR APPLICATION IN THERAPY
NO20071642L (en) N-Benzenesulfonyl-substituted anilino-pyrimidine analogs
NO20052802L (en) Pyrrolopyrimidinderivativer
NO20075624L (en) Novel histamine H3 receptor ligands and their therapeutic uses
CY1116885T1 (en) Substituted cyclohexylmethyl derivatives
TW200740752A (en) 4-Biarylyl-1-phenylazetidin-2-ones
SE0400284D0 (en) Novel compounds
NO20080394L (en) N- (arylalkyl) -1H-pyrrolopyridine-2-carboxamide derivatives, preparation and use thereof
MX2011007864A (en) Scriptaid isosteres and their use in therapy.
NO20070570L (en) Compounds.
NO20075734L (en) Thiophene compounds and thrombopoietin receptor activators
NO20071008L (en) Process for the preparation of N-piperidino-1,5-diphenylpyrazole-3-carboxamide derivatives
NO20062021L (en) Redirected pentanols, their methods of preparation, and their use as antiflogistics
NO20070089L (en) DPP-IV inhibitors
ATE482933T1 (en) SULFOPYRROL DERIVATIVES
NO20082226L (en) 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
DK1303514T3 (en) Process for the preparation of azacycloalkanoylaminothiazoles
DK1532098T3 (en) Process for the preparation of nitro oxide derivatives of naproxen
NO20072310L (en) 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives
NO20062202L (en) Amidomethyl-substituted 2- (4-sulfonylamino) -3-hydroxy-3,4-dihydro-2H-chromene-6-yl derivatives, processes and intermediates for their preparation, and drugs containing these compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application